Methylenedioxycyclopropylmethylamphetamine
| Clinical data | |
|---|---|
| Other names | 3,4-Methylenedioxy-N-cyclopropylmethylamphetamine; MDCPM; N-Cyclopropylmethyl-MDA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H19NO2 |
| Molar mass | 233.311 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
MDCPM, also known as 3,4-methylenedioxy-N-cyclopropylmethylamphetamine or as N-cyclopropylmethyl-MDA, is a drug.[1] It is the N-cyclopropylmethyl derivative of MDMA.[1]
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDCPM's minimum dose as 10 mg orally and its duration as unknown.[1] MDCPM produces few to no effects.[1]
History
MDCPM was described in a patent by Horrom in 1972.[2] Subsequently, it was described in greater detail by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved).[1]
Chemistry
Synthesis
The chemical synthesis of MDCPM has been described.[1]
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]
See also
References
- ^ a b c d e f g h Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ^ U.S. patent 3,689,504
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.